Last reviewed · How we verify
Antithrombotic Agent — Competitive Intelligence Brief
marketed
Antithrombotic Agent
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Antithrombotic Agent (Antithrombotic Agent) — Oslo University Hospital. Antithrombotic agents prevent blood clot formation by inhibiting platelet aggregation or coagulation cascade pathways.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Antithrombotic Agent TARGET | Antithrombotic Agent | Oslo University Hospital | marketed | Antithrombotic Agent | ||
| Conventional antithrombotic strategy | Conventional antithrombotic strategy | Duk-Woo Park, MD | marketed | Antithrombotic agents (antiplatelet and/or anticoagulant) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antithrombotic Agent class)
- Oslo University Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Antithrombotic Agent CI watch — RSS
- Antithrombotic Agent CI watch — Atom
- Antithrombotic Agent CI watch — JSON
- Antithrombotic Agent alone — RSS
- Whole Antithrombotic Agent class — RSS
Cite this brief
Drug Landscape (2026). Antithrombotic Agent — Competitive Intelligence Brief. https://druglandscape.com/ci/antithrombotic-agent. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab